§ 01 / Reference
Peptide index
51 compounds catalogued. Each entry is graded on evidence strength. Blind-purchase testing data appears as the independent assay program comes online.
51
Compounds
15
Tier 1
11
Speculative
—
Mean pass
Search
Evidence tier
Category
Showing
51 / 51
| # | Compound ▲ | Also known as | Category ↕ | Evidence ↕ | Pass % ↕ | N ↕ | Supp. ↕ | |
|---|---|---|---|---|---|---|---|---|
| 01 | 5-Amino 1MQ | Small-molecule nicotinamide N-methyltransferase (NNMT) inhibitor (not a peptide; commonly sold in peptide-market channels) | Other | SPECULATIVE | — | — | — | → |
| 02 | AOD-9604 | Modified fragment of human growth hormone amino acids 176-191 | Metabolic | TIER 3 · Preclinical | — | — | — | → |
| 03 | ARA-290 | 11-amino-acid peptide derived from erythropoietin; innate repair receptor (IRR) agonist | Healing | TIER 2 · Translational | — | — | — | → |
| 04 | B7-33 | Modified single-chain relaxin-2 analog; biased RXFP1 receptor agonist | Healing | SPECULATIVE | — | — | — | → |
| 05 | BPC-157 | Synthetic 15-amino-acid pentadecapeptide | Healing | TIER 3 · Preclinical | — | — | — | → |
| 06 | Bremelanotide | Synthetic cyclic heptapeptide analog of alpha-MSH; non-selective melanocortin receptor agonist | Other | TIER 1 · Clinical | — | — | — | → |
| 07 | Cagrilintide | Long-acting amylin analog; AMY1/2/3 receptor agonist | Metabolic | TIER 2 · Translational | — | — | — | → |
| 08 | CagriSema | Fixed-ratio coformulation: cagrilintide (amylin agonist) plus semaglutide (GLP-1 agonist) | Metabolic | TIER 2 · Translational | — | — | — | → |
| 09 | Calcitonin | 32-amino-acid peptide hormone; calcitonin receptor agonist; salmon-derived form is most clinically used | Other | TIER 1 · Clinical | — | — | — | → |
| 10 | Cerebrolysin | Porcine-brain-derived peptide preparation (low-molecular-weight neuropeptides plus free amino acids) | Cognitive | TIER 2 · Translational | — | — | — | → |
| 11 | CJC-1295 | Tetrasubstituted GHRH(1-29) analog; DAC variant covalently binds albumin for extended half-life | GH secretagogue | SPECULATIVE | — | — | — | → |
| 12 | Dermorphin | 7-amino-acid peptide (Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2) from amphibian skin; mu-opioid agonist | Other | SPECULATIVE | — | — | — | → |
| 13 | Desmopressin | Synthetic analog of vasopressin; selective V2-receptor agonist | Other | TIER 1 · Clinical | — | — | — | → |
| 14 | Dihexa | Synthetic hexapeptide; angiotensin IV analog | Cognitive | SPECULATIVE | — | — | — | → |
| 15 | DSIP | 9-amino-acid peptide isolated from rabbit brain in 1977 | Cognitive | TIER 3 · Preclinical | — | — | — | → |
| 16 | Dulaglutide | GLP-1 analog fused to IgG4 Fc fragment; long-acting GLP-1 receptor agonist | Metabolic | TIER 1 · Clinical | — | — | — | → |
| 17 | Epitalon | Synthetic tetrapeptide Ala-Glu-Asp-Gly | Cognitive | SPECULATIVE | — | — | — | → |
| 18 | Exenatide | Synthetic version of exendin-4 (Gila monster saliva); GLP-1 receptor agonist | Metabolic | TIER 1 · Clinical | — | — | — | → |
| 19 | FOXO4-DRI | D-amino-acid retro-inverso peptide designed to interfere with FOXO4-p53 interaction | Cognitive | SPECULATIVE | — | — | — | → |
| 20 | GHK-Cu | Naturally occurring tripeptide (Gly-His-Lys) complexed with copper(II) | Healing | TIER 2 · Translational | — | — | — | → |
| 21 | GHRP-2 | Synthetic hexapeptide; ghrelin / GHS-R1a receptor agonist | GH secretagogue | TIER 2 · Translational | — | — | — | → |
| 22 | GHRP-6 | Synthetic hexapeptide; ghrelin / GHS-R1a receptor agonist; first characterized GHRP | GH secretagogue | SPECULATIVE | — | — | — | → |
| 23 | Glutathione | Tripeptide; endogenous antioxidant (not a classical peptide hormone) | Other | TIER 2 · Translational | — | — | — | → |
| 24 | Hexarelin | Synthetic hexapeptide; potent ghrelin/GHS-R1a agonist; also CD36 ligand | GH secretagogue | TIER 3 · Preclinical | — | — | — | → |
| 25 | Humanin | 24-amino-acid mitochondrial-derived peptide encoded within the MT-RNR2 gene | Cognitive | TIER 3 · Preclinical | — | — | — | → |
| 26 | IGF-1 LR3 | Modified IGF-1 analog with N-terminal extension and Arg-for-Glu substitution at position 3; reduced IGFBP affinity | GH secretagogue | SPECULATIVE | — | — | — | → |
| 27 | Ipamorelin | Pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) ghrelin / GHS-R1a receptor agonist | GH secretagogue | SPECULATIVE | — | — | — | → |
| 28 | Kisspeptin-10 | 10-amino-acid C-terminal fragment of kisspeptin; KISS1R (GPR54) receptor agonist | Other | TIER 2 · Translational | — | — | — | → |
| 29 | Liraglutide | Acylated GLP-1 receptor agonist; predecessor of semaglutide | Metabolic | TIER 1 · Clinical | — | — | — | → |
| 30 | LL-37 | 37-amino-acid cationic antimicrobial peptide; human cathelicidin | Healing | TIER 3 · Preclinical | — | — | — | → |
| 31 | Melanotan II | Synthetic cyclic heptapeptide analog of alpha-MSH; broad melanocortin receptor agonist | Other | TIER 3 · Preclinical | — | — | — | → |
| 32 | MK-677 | Non-peptide spiroindoline small molecule; oral ghrelin / GHS-R1a receptor agonist | GH secretagogue | TIER 2 · Translational | — | — | — | → |
| 33 | MOTS-c | 16-amino-acid mitochondrial-derived peptide encoded within the 12S rRNA gene | Metabolic | TIER 3 · Preclinical | — | — | — | → |
| 34 | Octreotide | Synthetic cyclic octapeptide analog of somatostatin; SSTR2/SSTR5 agonist | Other | TIER 1 · Clinical | — | — | — | → |
| 35 | Oxytocin | Nonapeptide (9 amino acids with disulfide bond); OT receptor agonist | Other | TIER 1 · Clinical | — | — | — | → |
| 36 | PE 22-28 | 7-amino-acid fragment of B-cell-derived PEPITEM protein | Healing | SPECULATIVE | — | — | — | → |
| 37 | Retatrutide | Triple agonist of GIP, GLP-1, and glucagon receptors | Metabolic | TIER 2 · Translational | — | — | — | → |
| 38 | Selank | Synthetic heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro (stabilized analog of tuftsin) | Cognitive | TIER 3 · Preclinical | — | — | — | → |
| 39 | Semaglutide | Long-acting GLP-1 receptor agonist | Metabolic | TIER 1 · Clinical | — | — | — | → |
| 40 | Semax | Synthetic heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro (stabilized ACTH(4-10) fragment analog) | Cognitive | TIER 3 · Preclinical | — | — | — | → |
| 41 | Sermorelin | Synthetic GHRH(1-29)-NH2 — minimum bioactive fragment of endogenous GHRH | GH secretagogue | TIER 1 · Clinical | — | — | — | → |
| 42 | Somatropin | Recombinant 191-amino-acid human growth hormone | GH secretagogue | TIER 1 · Clinical | — | — | — | → |
| 43 | SS-31 | Synthetic mitochondria-targeted tetrapeptide that binds cardiolipin in the inner mitochondrial membrane | Cognitive | TIER 2 · Translational | — | — | — | → |
| 44 | TB-500 | Naturally occurring 43-amino-acid peptide (Tβ4); TB-500 often used commercially as a synonym though technically refers to a synthetic fragment | Healing | TIER 2 · Translational | — | — | — | → |
| 45 | Teduglutide | Recombinant analog of GLP-2; selective GLP-2 receptor agonist | Metabolic | TIER 1 · Clinical | — | — | — | → |
| 46 | Teriparatide | Recombinant human parathyroid hormone amino acids 1-34 | Other | TIER 1 · Clinical | — | — | — | → |
| 47 | Tesamorelin | Stabilized human growth hormone-releasing hormone (1-44) analog | GH secretagogue | TIER 1 · Clinical | — | — | — | → |
| 48 | Tesofensine | Triple monoamine reuptake inhibitor (noradrenaline, dopamine, serotonin) | Metabolic | TIER 2 · Translational | — | — | — | → |
| 49 | Thymosin Alpha-1 | 28-amino-acid peptide derived from prothymosin alpha | Healing | TIER 2 · Translational | — | — | — | → |
| 50 | Thymulin | 9-amino-acid thymic peptide; biologically active only when bound to zinc | Healing | TIER 3 · Preclinical | — | — | — | → |
| 51 | Tirzepatide | Dual GIP / GLP-1 receptor agonist | Metabolic | TIER 1 · Clinical | — | — | — | → |
◉ Pass % / N columns populate as our blind-purchase assay program brings samples through the lab queue. Until then, the compound list is organized by evidence tier and category only.